Free Call: 1800 792 676
Seminar Invitation: Pitfalls for SMEs in protecting and claiming incentives for new developments
Presented by:
- Craig Humphris (Wrays)
- Mark Jeffreson (UHY Haines Norton)
- David Greatwich (Swanson Reed)
Join Swanson Reed, UHY Haines Norton and Wrays for a practical workshop that will focus on the problems that every day companies face in protecting, and claiming incentives for their new products.
You will hear from three industry experts on a range of topics, including tax issues, R&D tax incentives and patent protection.
On conclusion of the presentation, participants will have an opportunity to ask the panel any specific questions in a friendly and constructive forum.
| Time | Presentation | Presenter | |
| 8:30am – 9:00am: | Session 1: Protecting Intellectual Property (IP) | Craig Humphris | |
| 9:00am – 9:30am: | Session 2: IP & Relevant Tax Considerations | Mark Jeffreson | |
| 9:30am – 10:00am: | Session 3: R&D Tax Incentives | David Greatwich | |
| 10:00am – 10:30am: | Session 4: Panel Q&A and Networking Opportunity | ||
| Craig Humphris | Mark Jeffreson | David Greatwich |
 |
 |
 |
| View Craig’s bio | View Mark’s bio | View David’s bio |
Adelaide Seminar:
Wednesday, 18th June 2014
8:30am – 10:30am
Hilton Adelaide
233 Victoria Square
Adelaide, 5000
Cost: Free!
Register Before: Friday 13th June
Full attendance at this workshop will yield 2 CPE hours towards the Tax Practitioners Board’s (TPB) CPE requirements.
Contact Amy Nolan for more information:
Ph: 08 8121 7850
Mob: 0435 713 493
Are you Eligible to claim R&D? Take our R&D Eligibility Survey and find out.
Latest News
Despite Switzerland being known as one of the most innovative nations, latest reports have shown a 10% decline in the country’s research and development spending. This comes as a surprise due to the fact that worldwide R&D expenditure has reached an all-time high of $782 billion. The biggest Swiss companies invested $27.5 billion into R&D in 2018. The majority of the decline has come from Basel-based giant pharmaceutical companies Roche and Novartis. Roche spent around $1 billion less on R&D […]
In 2016 the Johnson & Johnson Partnering Office was launched to enable innovative research and development (R&D) for Queensland’s life sciences industry. The R&D facility is housed at Queensland University of Technology’s (QUT) Institute of Health and Biomedical Innovation. The R&D centre serves as a strong platform to identify and nurture life science and research collaborations. Following on from the launch in 2016, the Queensland government has now announced a significant extension of the Johnson & Johnston R&D Office at […]
News & Research
News & Research
News & ResearchDespite Switzerland being known as one of the most innovative nations, latest reports have shown a 10% decline in the country’s research and development spending. This comes as a surprise due to the fact that worldwide R&D expenditure has reached […]
In 2016 the Johnson & Johnson Partnering Office was launched to enable innovative research and development (R&D) for Queensland’s life sciences industry. The R&D facility is housed at Queensland University of Technology’s (QUT) Institute of Health and Biomedical Innovation. The […]
